首页> 外文期刊>Transplant immunology >Expression patterns of Toll like receptor (TLR)-2, TLR-4 and myeloid differentiation primary response gene 88 (MYD88) in renal transplant patients developing allograft dysfunction; a cohort study
【24h】

Expression patterns of Toll like receptor (TLR)-2, TLR-4 and myeloid differentiation primary response gene 88 (MYD88) in renal transplant patients developing allograft dysfunction; a cohort study

机译:肾移植患者发育患者的损伤(TLR)-2,TLR-4和骨髓分化初级反应基因88(MYD88)的表达模式肾移植患者开发同种异体移植功能障碍; 队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

This cohort intends to determine the sequential dynamic changes in Toll-like receptor (TLR)-4, TLR-2, and myeloid differentiation primary response gene 88 (MYD88) mRNA expressions in PBMCs and biopsy samples from kidney allograft recipients in relation to graft function. This study enrolled 52 renal transplant patients, 27 with well functioning graft (WFG) and 25 graft dysfunction (GD). Peripheral blood samples pre- and post-transplantation (days 2, 90 and 180) were collected to analyze mRNA expression levels of TLR-2, TLR-4, and MYD88 genes in relation to allograft function during one-year follow up. The mean dynamic changes of post-transplant TLR-2, TLR-4, and MYD88 mRNA expressions were significantly higher in GD compared to WFG patients (P = .001). ROC curve analysis based on glomerular filtration rate (GFR) index showed the area under curve (AUC) values for the genes: TLR-2(0.89;P .001), TLR-4(0.86;P .001), and MYD88(0.75;P = .003) in the third month post-transplantation for GD diagnosis. The calculated AUCs for the expressions of genes in allograft biopsies were 0.94(TLR-2), 0.95(TLR-4), and 0.98(MYD88) in the sixth month post-transplant based on pathology report (P .001). Our results indicate that sequential monitoring of the expression patterns of TLR-2, TLR-4, and MYD88 in PBMCs and biopsy samples could be considered as predictive biomarkers for early and late kidney allograft function.
机译:该队列旨在确定来自肾同种异体移植接受者的PBMCS和活检样品中的Toll样受体(TLR)-4,TLR-2和骨髓分化初级反应基因88(MYD88)mRNA表达的顺序动态变化与移植物功能相关。本研究注册了52例肾移植患者,27例,具有良好的功能移植物(WFG)和25个移植物功能障碍(GD)。收集外周血样品(移植后的外周血样品(第2,90和第90和180),以分析TLR-2,TLR-4和MyD88基因的mRNA表达水平与同种异体移植功能相比,在一年的跟进期间。与WFG患者相比,移植后TLR-2,TLR-4和MYD88 mRNA表达的平均动态变化显着高(P = .001)。基于肾小球过滤速率(GFR)指数的ROC曲线分析显示了基因的曲线(AUC)值下的面积:TLR-2(0.89; P <.001),TLR-4(0.86; P <.001) ,和MyD88(0.75; p = .003)在移植后的第三个月内进行GD诊断。基于病理报告的移植后第六个月,对同种异体移植活组织检查中的基因表达的计算的AUC为0.94(TLR-2),0.95(TLR-4)和0.98(MYD88)(P <.001)。我们的结果表明,PBMC和活检样品中TLR-2,TLR-4和MYD88中的表达模式的顺序监测可被认为是早期和晚期肾同种异体移植功能的预测生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号